End-of-day quote
Other stock markets
|
||
- USD | - |
|
Sales 2024 * | - | Sales 2025 * | 54.14M 74.15M | Capitalization | 96.79M 133M |
---|---|---|---|---|---|
Net income 2024 * | -56M -76.7M | Net income 2025 * | -24M -32.87M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.79 x |
P/E ratio 2024 * |
-1.64
x | P/E ratio 2025 * |
-4.2
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.91% |
Latest transcript on Cellectar Biosciences Inc
Managers | Title | Age | Since |
---|---|---|---|
James Caruso
CEO | Chief Executive Officer | 65 | 15-06-14 |
Chad Kolean
DFI | Director of Finance/CFO | 59 | 14-05-27 |
Andrei Shustov
CTO | Chief Tech/Sci/R&D Officer | - | 23-02-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Driscoll
BRD | Director/Board Member | 73 | 17-04-06 |
Douglas Swirsky
CHM | Chairman | 54 | 17-04-06 |
John Neis
BRD | Director/Board Member | 68 | 08-01-31 |
1st Jan change | Capi. | |
---|---|---|
+54.23% | 815B | |
+44.25% | 654B | |
-6.23% | 354B | |
+21.45% | 337B | |
+10.92% | 302B | |
+18.45% | 247B | |
+2.09% | 229B | |
+13.03% | 219B | |
+9.03% | 171B |